OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer

Published on February 13, 2025

oncology assets for patients. OnCusp raised an oversubscribed $100 million Series A financing round in January 2024,co-led by Novo Holdings,

Continue reading on website
Other news

Cangzhou, Hebei, China: Experience the Magic of Year of the Snake Celebrations with Lantern Festivals and Traditional Iron Flower Performances

February 13, 2025
Asia , Asia tourism news , Cangzhou , Cangzhou tourism news , china , China Tourism News , Chinese New Year tourism , cultural tourism ,

DeSantis’ proposed budget guts low-income, minority initiatives

February 13, 2025
workforce education for high-demand jobs, providing family-first tax relief, ensuring that Florida’s students can access a quality education